Xenetic Biosciences, Inc. (XBIO)
3.53
-0.03
(-0.84%)
USD |
NASDAQ |
Apr 17, 16:00
3.59
+0.06
(+1.70%)
After-Hours: 20:00
Xenetic Biosciences EPS Diluted (Quarterly) : -0.2528 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -1.03 |
| BioStem Technologies, Inc. | -0.67 |
| Iovance Biotherapeutics, Inc. | -0.1767 |
| Protokinetix, Inc. | -0.0002 |
| GB Sciences, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.5791M |
| Revenue (Quarterly) | 0.7663M |
| Total Expenses (Quarterly) | 1.345M |
| Enterprise Value | 0.2055M |
| Profit Margin (Quarterly) | -75.57% |
| Earnings Yield | -45.77% |
| Normalized Earnings Yield | -45.77 |